QQQ $ 481.74 $ 1.45 (0.3 %)
DIA $ 391.56 $ 0.43 (0.11 %)
SPY $ 545.33 $ 1.11 (0.2 %)
TLT $ 90.13 $ -1.65 (-1.8 %)
GLD $ 215.59 $ 0.58 (0.27 %)
$ 3.72
-- x --
-- x --
-- - --
$ 2.09 - $ 5.80
391
na
na
$ 1.24
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 the-daily-biotech-pulse-fda-wants-omicron-targeted-covid-19-boosters-provention-bio-clears-hits-hurdle-for-diabetes-prevention-drug-oxford-biomedica-astrazeneca-strike-vaccine-pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

 benzinga-before-the-bell-kohls-deal-talks-cancellation-teslas-racial-discrimination-lawsuit-nios-strong-june-deliveries-and-other-top-financial-stories-friday-july-1

CNBC Why Kohl’s Shares Are Plunging Today

 the-daily-biotech-pulse-immunitybio-reports-positive-readout-valneva-starts-late-stage-chikungunya-vaccine-study-sio-gene-shelves-parkinsons-program

Here's a roundup of top developments in the biotech space over the last 24 hours:

 oxford-biomedica-homology-medicines-enter-deal-to-expand-viral-vector-offerings

London-listed cell and gene therapy Oxford Biomedica Plc (OTC: OXBDF) said it would form a viral vector manufacturing business ...

Core News & Articles

-Bloomberg https://www.bloomberg.com/news/articles/2021-12-02/possible-new-links-between-astra-vaccine-and-blood-clots-found

Core News & Articles

-Reuters https://www.reuters.com/world/uk/delta-subvariant-wont-change-covid-picture-oxford-vaccine-chief-says-2021-10-20/

Core News & Articles

-Reuters https://www.reuters.com/business/healthcare-pharmaceuticals/covid-jab-protection-wanes-within-six-months-uk-researche...

Core News & Articles

-Reuters

Core News & Articles

-FT https://www.ft.com/content/c5297d58-ad6d-490f-89e0-74f9c13377e4

 the-daily-biotech-pulse-spero-secures-niaid-funding-glaxosmithkline-releases-covid-19-data-biontech-gets-new-cfo

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

-Reuters

Core News & Articles

Positive high-level results from the primary analysis of the Phase III trial of AZD1222 in the US have confirmed vaccine effica...

Core News & Articles

-Reuters

Core News & Articles

-FT https://www.ft.com/content/e9bbd4fe-e6bf-4383-bfd3-be64140a3f36

Core News & Articles

-Reuters https://www.reuters.com/article/uk-health-coronavirus-britain/there-are-4000-variants-of-virus-that-causes-covid-19-u...

Core News & Articles

-Reuters

Core News & Articles

Increased efficacy with longer inter-dose interval Protection of over 70% starting after a first dose First indication of red...

Core News & Articles

https://asia.nikkei.com/Spotlight/Coronavirus/Japan-to-mass-produce-AstraZeneca-COVID-vaccine-soon